Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MMPJOE's Profile
Displaying 251-300 of 862 result(s).
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:34:25 PM
Veneto a great great business any c (1)
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:30:39 PM
But that does not mean it’s looke
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:28:43 PM
No I don’t control people or thei
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:26:59 PM
Again wild statements and hugely ri (1)
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:23:27 PM
It certainly is much or a benefit t
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:22:30 PM
No not at all no serious funding so (1)
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:19:44 PM
I didn’t talk about this publical (3)
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:09:57 PM
Smart post we will See
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:07:38 PM
Well 40 million at 40 cents with an
GNBTQ Generex Biotechnology Corp.
11/30/2019 1:05:40 PM
It’s called alpha capital and all
GNBTQ Generex Biotechnology Corp.
11/30/2019 12:59:55 PM
Not sure about that without my glas
GNBTQ Generex Biotechnology Corp.
11/30/2019 12:46:34 PM
Just because I tempered my anger an (2)
GNBTQ Generex Biotechnology Corp.
11/30/2019 12:44:01 PM
And I have no clue how you would ev (1)
GNBTQ Generex Biotechnology Corp.
11/30/2019 12:39:58 PM
As I said yesterday we will find ou
GNBTQ Generex Biotechnology Corp.
11/30/2019 12:36:13 PM
The most I can do, jail and massive
GNBTQ Generex Biotechnology Corp.
11/30/2019 12:34:19 PM
Recall retired shares I do not unde (1)
GNBTQ Generex Biotechnology Corp.
11/30/2019 12:02:31 PM
First time we did the dividend it w
GNBTQ Generex Biotechnology Corp.
11/30/2019 11:28:38 AM
Just so you understand it’s not a
GNBTQ Generex Biotechnology Corp.
11/25/2019 9:41:32 AM
Generex's well-designed MSO model c (5)
GNBTQ Generex Biotechnology Corp.
11/14/2019 2:13:10 PM
Triple negative is the biggest out (1)
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:37:50 PM
And ONE big CORRECTION and as I’v
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:32:02 PM
And yes of course if I’m using sh
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:30:16 PM
Sure but it’s not my study, just
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:22:49 PM
Also not material because we spend
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:19:31 PM
No it’s not a material event they
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:08:03 PM
One more time if I haven’t announ
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:02:41 PM
I never said you you jumped in and
GNBTQ Generex Biotechnology Corp.
11/14/2019 1:01:38 PM
Altucell as I said on last two conf
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:59:54 PM
Buzz off your nuts you attack me on
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:54:58 PM
Never pissed off just frustrated, I
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:47:53 PM
Ok well then you didn’t listen or
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:45:56 PM
Yeah let’s have insiders drive up
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:44:28 PM
So myself and salvo put over 1 mill
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:36:54 PM
Yes but as I said on the conf call
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:35:43 PM
Only way to hit endpoint was to rec
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:32:38 PM
Who says they haven’t begun
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:31:28 PM
No it did not wrong, your absolutel
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:27:38 PM
Doc I really like your bashing, are
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:16:13 PM
Not true at all the phase two back
GNBTQ Generex Biotechnology Corp.
11/14/2019 12:07:17 PM
Omg, 2012 last appraisal, same drug
GNBTQ Generex Biotechnology Corp.
11/14/2019 10:16:12 AM
Sign a NDA with generex and I’ll
GNBTQ Generex Biotechnology Corp.
11/14/2019 10:14:49 AM
Really good questions for conf call
GNBTQ Generex Biotechnology Corp.
11/14/2019 9:41:32 AM
I can’t answer your illegal quest
GNBTQ Generex Biotechnology Corp.
11/12/2019 7:37:46 PM
Guy is a bad guy that’s why terry
GNBTQ Generex Biotechnology Corp.
11/12/2019 6:59:25 PM
Bad bad boy Brian podalack I’m su (2)
GNBTQ Generex Biotechnology Corp.
11/12/2019 1:15:50 PM
Can only update when there is somet
GNBTQ Generex Biotechnology Corp.
11/12/2019 1:05:59 PM
One step at a time.
GNBTQ Generex Biotechnology Corp.
11/12/2019 1:04:59 PM
What I did say last conf call I wou
GNBTQ Generex Biotechnology Corp.
11/12/2019 12:57:49 PM
You will have to ask that in a publ
GNBTQ Generex Biotechnology Corp.
11/12/2019 12:55:01 PM
No incorrect he quoted me from the
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >
Deliver breaking news, insightful commentary, and exclusive reports. Get in touch benzingaheadline@gmail.com. Target readers who trust our platform to stay ahead of the curve.

Recent Articles

  • Key Insights on Upcoming Housing Forum and Media Availability
  • Consumer Watchdog Confronts Industry on Pricing Transparency
  • Proposed Settlement Announcement for Cencora Stockholders
  • Celebrating Discounts: Root One's Anniversary Sale Exploration
  • Iceland's Stable Credit Ratings and Economic Outlook Explained
  • Welsbach Technology Metals and Evolution Metals Combine Forces
  • Steakholder Foods to Implement Major ADS Split Adjustment
  • Children’s Place: Resilient Performance Amid Challenges
  • Welsbach Technology Metals: New Chapter with Evolution Metals
  • DIH Holding US, Inc. Faces Nasdaq Compliance Challenges Ahead
  • Portillo's Welcomes Denise Lauer as New CMO to Drive Growth
  • Sonoro Gold Corp Expands Private Placement Amid Investor Interest
  • Key Insights on Nyxoah's Transparency Notifications Shift
  • Integral Metals Extends Marketing Services Collaboration
  • Portillo’s Welcomes Denise Lauer as New Chief Marketing Officer
  • DBV Technologies Unveils New ATM Program for Investor Funding
  • DBV Technologies Launches New At-The-Market Program on Nasdaq
  • Nyxoah SA Reports Significant Transparency Update Announcement
  • American Healthcare REIT's Key Conference Participation and Goals
  • A Comprehensive Look at Qualys Short Sales and Market Sentiment
  • Understanding Recent Trends in SBA Communications' Short Interest
  • Understanding SuperCom’s Short Interest Trends and Insights
  • How Investing in Norfolk Southern Can Change Your Future Wealth
  • Exploring the ZYN ETF: A Strategic Investment in Tobacco
  • Children's Place Sees Shift in Sales Amid New Initiatives
  • Tronox Holdings PLC Faces Investor Scrutiny Over Stock Decline
  • Blue Water Acquisition Corp. III Makes $10 Billion Bid to Acquire Citgo
  • PINTEC Partners with ZIITECH: Strategic Share Exchange
  • Lipocine Announces Key Presentation at Global Investment Conference
  • Shapellx's Dual Triumph at Muse Design Awards Reinforces Dominance
  • Crown Castle CFO to Present at Key Investment Conference
  • Old National Bancorp's Participation in Upcoming Finance Conference
  • Exploring Growth: The Rise of Popular Inc. Stock Value
  • Tronox Holdings Faces Investigation Amid Investor Concerns
  • Understanding the Decline in Charles Schwab's Share Price
  • Exciting Offers for the RAM 1500 at Chris Auffenberg Dealerships
  • Innovative Apprenticeship Program by Syntec Optics for Future Leaders
  • Concerns Rise Over Carbon Pipeline Bills and Lobbyist Influence
  • Tampa General Hospital Achieves Prestigious FACT Accreditation
  • Southwest Gas Transitions to Full Regulatory Focus After Centuri Sale
  • Investors in Lineage, Inc. Can Join Class Action Lawsuit Now
  • Upcoming Earnings Call Highlights for Vail Resorts, Inc.
  • Artivion to Show Innovations at Esteemed Healthcare Conference
  • Arthur J. Gallagher & Co. Announces Upcoming Investor Meeting
  • Explore American Healthcare REIT's Upcoming Conference Insights
  • ProCure Proton Therapy Center Advocates for Prostate Cancer Care
  • Wing It On! Achieves Remarkable Success at National Wing Fest
  • Trends in Used Aircraft Prices: Jets Down, Piston Singles Steady
  • Engaging Moments Ahead: Gyre Therapeutics at Major Conference
  • Innovative Apprenticeship Program Launches at Syntec Optics
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site